NASDAQ: FLGCFlora Growth Corp Stock
$0.47+0.03 (+6.82%)
Updated Dec 5, 2022
FLGC Price
$0.47
Fair Value Price
$0.54
Market Cap
$36.14M
52 Week Low
$0.37
52 Week High
$2.38
P/E
N/A
P/B
0.67x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.35
Operating Cash Flow
N/A
Beta
1.91
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FLGC Overview
Flora Growth Corp. offers medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies in the U.S. and internationally. Flora Growth sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth was incorporated in 2019 and is headquartered in Toronto, Ontario, Canada.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FLGC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FLGC ($0.47) is undervalued by 14.11% relative to our estimate of its Fair Value price of $0.54 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
FLGC ($0.47) is not significantly undervalued (14.11%) relative to our estimate of its Fair Value price of $0.54 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FLGC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more FLGC due diligence checks available for Premium users.
Be the first to know about important FLGC news, forecast changes, insider trades & much more!
FLGC News
Valuation
FLGC fair value
Fair Value of FLGC stock based on Discounted Cash Flow (DCF)
Price
$0.47
Fair Value
$0.54
Undervalued by
13.56%
FLGC ($0.47) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FLGC ($0.47) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FLGC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
19.29x
Market
21.63x
FLGC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.67x
Industry
1.78x
FLGC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FLGC's financial health
Profit margin
Revenue
$10.8M
Net Income
-$7.4M
Profit Margin
-68.6%
Assets to liabilities
Assets
$73.1M
Liabilities
$19.0M
Debt to equity
0.35
FLGC's short-term assets ($22.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FLGC's short-term assets ($22.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FLGC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.3M
Investing
-$157.0k
Financing
-$415.0k
FLGC vs Pharmaceutical Stocks
Flora Growth Stock FAQ
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.